Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy

NYSE · Healthcare · Profile

Johnson & Johnson (JNJ) stock profile and business model

What Johnson & Johnson does, how the business earns money, and how valuation, peers, ownership, and risk shape the TECHi profile.

Section freshness

Price Aug 19, 3:44 PM EDT · Statements Jun 27, 8:00 PM EDT

Investor profile snapshot

JNJ live price, business model and key metrics

Start with the live market print, then use this profile to connect Johnson & Johnson's operating model with revenue, margins, peer context, and investor risk.

RealtimeRealtime regular-session pricing

$274.15

▲ +$3.04(+1.12%)3:44 PM ET - vs previous closei

Quote as of Aug 19, 2026, 3:44 PM EDT

Realtime NYSE quote as of Aug 19, 2026, 3:44 PM EDT.

Market data source

Today61%

$270.56L Aug 19 '26$276.47H Aug 19 '26

52-week98%

$173.33$276.47

Long-term ranges5Y, 10Y, Since first print

5Y98%

$140.68L Jan 10 '25$276.47H Aug 19 '26

10Y99%

$109.16L Mar 23 '20$276.47H Aug 19 '26

Since first print99%

$46.25L Mar 9 '09$276.47H Aug 19 '26

Live price

$274.15

Live during market hours

Market cap

$661.73B

Equity scale

Analyst view

Buy

Target $272.50 (-0.60% implied)

Company · Profile

About Johnson & Johnson (JNJ)

Sector, leadership, and how Johnson & Johnson earns its revenue.

Healthcare

Johnson & Johnson

NYSE · JNJ · US

Overview for JNJ coming soon.

Sector: Healthcare
Industry: Pharmaceuticals
Country: US
Founded: 2006
Exchange: NYSE

Business identity

Johnson & Johnson company facts and operating footprint

Overview for JNJ coming soon.

Financials Forecast Peers

Sector: Healthcare
Industry: Pharmaceuticals
Founded: 2006
Country: US
Exchange: NYSE

Registration and filing identifiersShow

Asset type: Common Stock
Fiscal year end: December
Latest quarter: Jun 28, 2026
CIK: 0000200406

Key metrics

JNJ valuation, revenue and margin profile

Full statistics

Market cap: $661.73B; Equity scale

Revenue TTM: $97.93B; Trailing twelve months

Net margin: 21.48%; Profit after expenses

Revenue growth: 6.60%; Latest YoY quarter

Margin quality snapshot

Gross margin70.45%

Operating margin26.81%

Net margin21.48%

Competitors

JNJ competitors and peer context

Ticker	Company	Price	Move
LLY	Eli Lilly & Co.	$1,285	+4.80%
MRK	MRK	$152.65	+12.93%
PFE	PFE	$28.22	+3.57%

Risk heatmap

JNJ business risks investors should monitor

Valuation sensitivity

Elevated

31.85x

Use the forward P/E and PEG context before treating the profile as cheap or expensive.

Balance-sheet flexibility

Monitor

D/E 0.44 · CR 1.09

Debt load and near-term liquidity shape how much strategic patience the company has.

Growth durability

Monitor

6.60%

Latest YoY revenue growth is the first check on whether the business model is still expanding.

Market sensitivity

Monitor

Beta 0.23

Higher beta can amplify drawdowns when rates, earnings expectations, or sector appetite shift.

Regulatory and operating pressure

Elevated

Healthcare

Clinical, reimbursement, approval, and policy shifts can change revenue timing and product economics.

JNJ ownership and registration profile

Float shares: 2.41B

Insider ownership: 0.05%

Institutional ownership: 77.23%

Size & scale

Market cap: $661.73B

Enterprise value: $656.03B

Shares outstanding: 2.41B

Currency: USD

Visit Johnson & Johnson websitejnj.com

Frequently asked

Common questions.

What does Johnson & Johnson do?

The JNJ Profile page keeps the available company description, sector, industry, leadership, headquarters, workforce, and product context together.

Where does TECHi source the JNJ profile?

Profile fields come from the unified company record and provider data; unavailable identity fields remain blank rather than inferred.